galantamine has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, Y; Haga, Y; Hanazawa, T; Kamijo, Y; Usui, K; Yoshizawa, T | 1 |
Barkhof, F; Fox, NC; Korf, ES; Scheltens, P; van de Pol, LA; van der Flier, WM | 1 |
1 trial(s) available for galantamine and Atrophy
Article | Year |
---|---|
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
Topics: Age Factors; Aged; Alzheimer Disease; Apolipoprotein E4; Atrophy; Biomarkers; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Galantamine; Genetic Predisposition to Disease; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Neuropsychological Tests; Predictive Value of Tests; Prognosis | 2007 |
1 other study(ies) available for galantamine and Atrophy
Article | Year |
---|---|
Acute cholinergic syndrome in a patient with Alzheimer's disease taking the prescribed dose of galantamine.
Topics: Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Galantamine; Humans; Male; Syndrome; Tomography, X-Ray Computed | 2018 |